[Effect of MD-805, a synthetic thrombin inhibitor, on disseminated intravascular coagulation developing in hematological disorders].
D000328:Adult; D000368:Aged; D001120:Arginine / Q000031:analogs & derivatives; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D010875:Pipecolic Acids / Q000627:therapeutic use*; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors*
D010875:Pipecolic Acids; D013449:Sulfonamides; D005340:Fibrinogen; D001120:Arginine; D013917:Thrombin; C031942:argatroban